Search results
Medicare’s push to improve chronic care attracts businesses, but not many doctors
The Columbian· 3 days agoCarrie Lester looks forward to the phone call every Thursday from her doctors’ medical assistant, who asks how she’s doing and if she needs prescription refills. The assistant counsels her on ...
Walmart is closing its 'unsustainable' health centers
Quartz· 7 hours agoWalmart announced today that it is closing all 51 of its health centers across five states and its...
Threat of Stanislaus hospital closure has some Modesto residents concerned | Opinion
Modesto Bee via Yahoo News· 3 days agoAnesthesiology Opinion Trusted professionals “Stanislaus hospital could close after Medicare...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 day agoThe top line is likely to have been fueled by growth in the sales of pain...have driven sales of...
Analysis | Whatever happened to Biden’s public option?
Washington Post· 4 days agoAs we ramp up for the 2024 election, I’ve wondered why talk of the public option has disappeared....
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
Zacks via Yahoo Finance· 4 days agoAdded to this, a drastic increase in the aging population in recent times (daily, about 10,000...
California, Oregon eye universal health coverage
Healthcare Dive via Yahoo Finance· 7 days agoThe states' proposals, which resemble Medicare for All, need approval from the federal government and face pushback from major health systems and...
Supreme Court Puppet Master’s Consulting Firm Clients Exposed in Leak
Rolling Stone via Yahoo News· 1 day agoLeonard Leo’s consulting firm has worked for Eli Lilly, the Koch network, and a dark-money group...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA Today· 5 days agoPatients struggle to afford popular weight-loss drugs such as Wegovy as employers limit Insurance...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks· 2 days agoCollegium generates product revenues primarily from the sales of Xtampza ER, the Nucynta Products, Belbuca and Symproic. Belbuca and Symproic were added to Collegium’s portfolio following the ...
